$200 Million is the total value of Scale Management, LLC's 6 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HUBS | Hubspot, Inc. | $68,671,000 | +18.7% | 1,721,075 | 0.0% | 34.30% | +3.8% | |
| HZNP | Sell | Horizon Pharma plc | $44,420,000 | +56.3% | 1,710,451 | -22.4% | 22.19% | +36.7% |
| ALIM | Alimera Sciences, Inc. | $22,838,000 | -9.6% | 4,558,491 | 0.0% | 11.41% | -20.9% | |
| OREX | Sell | Orexigen Therapeutics, Inc. | $22,584,000 | +23.5% | 2,884,305 | -4.4% | 11.28% | +8.0% |
| EVDY | Everyday Health, Inc. | $22,217,000 | -12.8% | 1,727,632 | 0.0% | 11.10% | -23.7% | |
| RNG | Sell | RingCentral, Inc. | $19,462,000 | -1.8% | 1,269,568 | -4.4% | 9.72% | -14.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-06-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Alimera Sciences, Inc. | 9 | Q4 2020 | 16.6% |
| Horizon Pharma plc | 8 | Q3 2016 | 68.2% |
| Everyday Health, Inc. | 8 | Q3 2016 | 20.4% |
| Orexigen Therapeutics, Inc. | 8 | Q3 2016 | 11.3% |
| Hubspot, Inc. | 6 | Q1 2016 | 34.3% |
| RingCentral, Inc. | 3 | Q2 2015 | 11.3% |
| JFrog Ltd. | 1 | Q4 2020 | 99.6% |
| Bill.com Holdings, Inc. | 1 | Q4 2020 | 0.1% |
View Scale Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IPC The Hospitalist Company, Inc. | February 11, 2009 | 1,561,009 | 9.7% |
View Scale Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-02-12 |
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-05-26 |
| 13F-HR | 2016-03-02 |
| 13F-HR | 2015-11-18 |
| 13F-HR | 2015-07-29 |
| 13F-HR | 2015-06-02 |
| 13F-HR | 2015-05-19 |
| SC 13G | 2009-02-11 |
View Scale Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.